Achieve Life Sciences, Inc.ACHVNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank87
3Y CAGR+8.7%
5Y CAGR+29.3%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+8.7%/yr
vs +33.6%/yr prior
5Y CAGR
+29.3%/yr
Recent deceleration
Acceleration
-24.9pp
Decelerating
Percentile
P87
Within normal range
vs 5Y Ago
3.6x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $52.34M | +34.8% |
| 2024 | $38.84M | +42.5% |
| 2023 | $27.25M | -33.2% |
| 2022 | $40.80M | +23.3% |
| 2021 | $33.09M | +128.3% |
| 2020 | $14.49M | -12.3% |
| 2019 | $16.53M | +29.0% |
| 2018 | $12.81M | +93.2% |
| 2017 | $6.63M | -72.0% |
| 2016 | $23.72M | - |